Edition:
India

Intersect ENT Inc (XENT.OQ)

XENT.OQ on NASDAQ Stock Exchange Global Market

33.92USD
1:30am IST
Change (% chg)

$-0.17 (-0.51%)
Prev Close
$34.10
Open
$34.05
Day's High
$34.35
Day's Low
$33.85
Volume
44,153
Avg. Vol
65,999
52-wk High
$42.90
52-wk Low
$26.92

Chart for

About

Intersect ENT, Inc. is a commercial-stage drug-device company. The Company develops drugs for patients with ear, nose and throat (ENT) conditions. The Company has developed a drug releasing bioabsorbable implant technology that enables targeted and sustained release of therapeutic agents. This targeted drug delivery technology... (more)

Overall

Beta: --
Market Cap(Mil.): $894.66
Shares Outstanding(Mil.): 29.19
Dividend: --
Yield (%): --

Financials

BRIEF-Intersect ENT Reports Qtrly Loss Per Share $0.21

* Q1 EARNINGS PER SHARE VIEW $-0.24 -- THOMSON REUTERS I/B/E/S

02 May 2018

BRIEF-Intersect ENT Q4 Revenue $29.5 Million

* INTERSECT ENT REPORTS FOURTH QUARTER AND FULL YEAR 2017 RESULTS

28 Feb 2018

Competitors

  Price Chg
Medtronic PLC (MDT.N) $88.02 -0.40

Earnings vs. Estimates